Neurology Alert – April 1, 2014

April 1, 2014

• Monoclonal Amyloid Antibodies for the Treatment of Alzheimer’s Disease: More Disappointment

  Current trials with amyloid antibodies have not shown clinical benefit, but the results suggest that treating patients earlier in the course, or during the presymptomatic period, might be beneficial.

  Read more about Monoclonal Amyloid Antibodies for the Treatment of Alzheimer’s Disease: More Disappointment - Neurology Alert – April 1, 2014

• Optic and Auditory Involvement in Demyelinating Neuropathy

  Read more about Optic and Auditory Involvement in Demyelinating Neuropathy - Neurology Alert – April 1, 2014

• Severe Childhood Neuronopathy that Responds to Riboflavin

  Read more about Severe Childhood Neuronopathy that Responds to Riboflavin - Neurology Alert – April 1, 2014

• Bevacizumab for Newly Diagnosed Glioblastoma

  Read more about Bevacizumab for Newly Diagnosed Glioblastoma - Neurology Alert – April 1, 2014

• The Importance of the CSF Specimen for Antibody Determination in NMDA Receptor Encephalitis

  Read more about The Importance of the CSF Specimen for Antibody Determination in NMDA Receptor Encephalitis - Neurology Alert – April 1, 2014